Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pavlakis

Showing results (271-280 of 294) with videos related to

Pageof 30
Sort By:
Journal of Virology|January 18, 2013
Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposureMonica Vaccari, Brandon F Keele, Steven E Bosinger, et al.
Plos One|March 15, 2014
DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaquesRashmi Jalah, Viraj Kulkarni, Vainav Patel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2012
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17M M Vickers, C S Karapetis, D Tu, et al.
Journal for Immunotherapy of Cancer|November 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumorsKevin Conlon, Dionysios C Watson, Thomas A Waldmann, et al.
Journal of Virology|September 24, 2020
A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus MacaquesThomas Musich, Vishal Thovarai, David J Venzon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2015
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionTimothy R Fouts, Kenneth Bagley, Ilia J Prado, et al.
Viruses|September 28, 2021
Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent PlasmaThomas P Thomopoulos, Margherita Rosati, Evangelos Terpos, et al.
Lancet (London, England)|August 13, 2021
Towards a European strategy to address the COVID-19 pandemicViola Priesemann, Rudi Balling, Simon Bauer, et al.
Microorganisms|April 30, 2021
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control AnalysisVasiliki Pappa, Anthi Bouchla, Evangelos Terpos, et al.
Clinical Immunology (Orlando, Fla.)|September 18, 2014
Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaquesAntonio Valentin, Katherine McKinnon, Jinyao Li, et al.
Pageof 30

Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
Journal of Virology|January 18, 2013
Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposureMonica Vaccari, Brandon F Keele, Steven E Bosinger, et al.
Plos One|March 15, 2014
DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaquesRashmi Jalah, Viraj Kulkarni, Vainav Patel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2012
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17M M Vickers, C S Karapetis, D Tu, et al.
Journal for Immunotherapy of Cancer|November 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumorsKevin Conlon, Dionysios C Watson, Thomas A Waldmann, et al.
Journal of Virology|September 24, 2020
A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus MacaquesThomas Musich, Vishal Thovarai, David J Venzon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2015
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionTimothy R Fouts, Kenneth Bagley, Ilia J Prado, et al.
Viruses|September 28, 2021
Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent PlasmaThomas P Thomopoulos, Margherita Rosati, Evangelos Terpos, et al.
Lancet (London, England)|August 13, 2021
Towards a European strategy to address the COVID-19 pandemicViola Priesemann, Rudi Balling, Simon Bauer, et al.
Microorganisms|April 30, 2021
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control AnalysisVasiliki Pappa, Anthi Bouchla, Evangelos Terpos, et al.
Clinical Immunology (Orlando, Fla.)|September 18, 2014
Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaquesAntonio Valentin, Katherine McKinnon, Jinyao Li, et al.
Pageof 30